Indication

Ophthalmia neonatorum

Ophthalmia neonatorum, also referred to as neonatal conjunctivitis, is an acute inflammatory condition of the conjunctiva occurring in infants within the first 28 to 30 days of life. Read more about Ophthalmia neonatorum

26 drugs 23 manufacturers

Advertisement

Drugs that treat it

Common Ophthalmia neonatorum therapies.

Showing 19–26 of 26 drugs

Filter & compare in the drug finder →Opens the drug finder with Ophthalmia neonatorum preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ophthalmia neonatorum.

Ophthalmia neonatorum, also referred to as neonatal conjunctivitis, is an acute inflammatory condition of the conjunctiva occurring in infants within the first 28 to 30 days of life.

It most commonly develops through vertical transmission of infectious pathogens, particularly *Chlamydia trachomatis* or *Neisseria gonorrhoeae*, during passage through an infected birth canal, though chemical irritation from prophylactic ocular agents or other perinatal bacteria and viruses can also cause the disease.

Hallmark clinical features include conjunctival hyperemia, eyelid edema, chemosis, and ocular discharge that ranges from mild serous exudate to copious, purulent secretions.

If left untreated, highly virulent pathogens—most notably *N.

gonorrhoeae*—can rapidly breach the corneal epithelium, leading to corneal ulceration, perforation, and irreversible vision loss.

Personalize your experience

Follow Ophthalmia neonatorum and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it